ORC1 BAH domain (human, recombin

Confirm delete?

ORC1 BAH domain (human, recombinant)

Zoom

Cat No: 11919

Proteins - More Proteins

ORC1, a component of the Origin Recognition Complex, is necessary for the initiation of DNA replication. It is bound in complex with ORC2, ORC3, ORC4, ORC5, and ORC6. The BromoAdjacent Homology (BAH) domain of ORC1 recognizes histone 4 dimethylated at...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

ORC-1 1L PARC 2 3 4 5 6 bromo-adjacent

Product Overview:
ORC1, a component of the Origin Recognition Complex, is necessary for the initiation of DNA replication. It is bound in complex with ORC2, ORC3, ORC4, ORC5, and ORC6. The BromoAdjacent Homology (BAH) domain of ORC1 recognizes histone 4 dimethylated at lysine 20, which is enriched at replication origins (ORI).{21060} Chromatin immunoprecipitation and parallel sequencing of ORC1 DNA binding sites has been used to identify the ORI sites in HeLa cells.{25191} In addition to BAH mediated nucleosome recognition, ORC1 contains ATPase activity which is required for loading the minichromosome maintenance helicase complex.{25192} ORC1 levels oscillate during the cell cycle, decreasing during S phase following formation of pre-replication complexes.{25194} Mutations in ORC1 have been shown to cause Meier-Gorlin syndrome, a form of primordial dwarfism.{25193} This protein product contains the BAH domain region of ORC1.

Size	1 mg
Shipping	dry ice
Formulation	20 mM Tris, pH 8.0, with 50 mM sodium chloride and 20% glycerol
Purity	≥80%
Custom Code	3504.00
UNSPSC code	12352204

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.